More on PAVM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.21 |
|
|||
| Open | $5.13 | ||||
| 52 Wk High | $15.24 | ||||
| 52 Wk Low | $10.50 | ||||
| Day High | $5.13 | ||||
| Day Low | $4.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,212 | ||||
- Form 8-K PAVmed Inc. For: Aug 14
- PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
- Form SCHEDULE 13G/A PAVmed Inc. Filed by: NAGELBERG DAVID S
- Form 10-Q PAVmed Inc. For: Jun 30
- Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
- Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
- Lucid Diagnostics to Participate in Upcoming Investor Conferences
- PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026
- Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
- Form S-8 PAVmed Inc.
Entities mentioned with PAVM
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- S3 | View Related Stories »
- Maxim Group | View Related Stories »
- S1 | View Related Stories »
- Show More...
